关于英国药理学会 英国药理学会于1931年在牛津成立，致力于宣传推广药理学，在世界各地的药理学研究和应用中处于领先地位。学会是一个全球性的社区，包括超过60个国家的3500名成员。 BJCP临床药理学月 十月是临床药理学月！BJCP开放了临床药理学虚拟特刊的免费阅读，点击 这里 进入。 BJP 虚拟特刊 关于微小核糖核酸，眼药理学，G蛋白偶联受体和更多最新发现——欢迎点击 这里 ，查看最新的BJP虚拟特刊。 在BJP, BJCP和PRP上发表文章 想在BJP上发表文章吗？查看提供给中国作者的特别资源。点击 这里 了解。 如何在英国药理学会的期刊上发表文章——查看提供给中国作者们的新资源。点击 这里 了解。 Pharmacology Research Perspectives (PRP)征稿 征稿：药学领域的年轻学者和博士生 ——想在我们期刊发表文章吗？将你的研究和论文总结成一篇文章或综述，PRP欢迎你们的来稿！点击 这里 了解。 征稿：消极发现 ——消极也可以转变为积极。 历史上有些研究案例原本被认为有着“消极”的实验结果，但实际上却改变了这一领域或发现了新的药物治疗方法。PRP正在寻找突出了这类历史案例的综述文章。点击 这里 了解。 征稿：从事制药研究的人员 ——为何不考虑发表目前正搁置的项目中的数据呢？你可以将他们整理成内部报告的形式，使用PRP的格式即可。点击 这里 了解。 期刊介绍 British Journal of Pharmacology : IF 6.81, Rank 12/261 The British Journal of Pharmacology is a broad-based journal giving leading international coverage of all aspects of experimental pharmacology. It publishes high quality original research and authoritative reviews. Each year a range of themed issues are published and a must-read supplement, the Concise Guide to Pharmacology, is published biennially. The journal is now published in an online-only format. Issues are published fortnightly but are no longer printed; however, authors are still able to order offprints of their own articles through Author Services. British Journal of Clinical Pharmacology : IF 3.84, Rank 47/261 Published on behalf of the British Pharmacological Society, theBritish Journal of Clinical Pharmacologycontains papers and reports on all aspects of drug action in humans: review articles, mini review articles, original papers, commentaries, editorials and letters. The Journal enjoys a wide readership, bridging the gap between the medical profession, clinical research and the pharmaceutical industry. It also publishes research on new methods, new drugs and new approaches to treatment. Pharmacology Research Perspectives : PRP is jointly published by the American Society for Pharmacology and Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS), and Wiley.PRPis a bi-monthly open access journal that publishes a range of article types, including: target validation (preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development); drug discovery reviews (strategy, hypotheses, and data resulting in a successful therapeutic drug); frontiers in translational medicine (drug and target validation for an unmet therapeutic need); pharmacological hypotheses (reviews that are oriented to inform a novel hypothesis); and replication studies (work that refutes key findings and work that validates key findings).PRPpublishes papers submitted directly to the journal and those referred from the journals of ASPET and the BPS.
标签: 药理
